tiprankstipranks
COSCIENS Biopharma (CSCI)
NASDAQ:CSCI
US Market

COSCIENS Biopharma (CSCI) Income Statement

Compare
907 Followers

COSCIENS Biopharma Income Statement

Last quarter (Q3 2024), COSCIENS Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, COSCIENS Biopharma's net income was $-5.75M. See COSCIENS Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 4.50M$ 5.64M$ -90.00K$ 1.69M$ -69.00K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ -144.00K$ -9.00K$ -18.00K
EBITDA
$ -17.99M$ -26.05M$ -7.96M$ -6.28M$ -5.92M
Operating Income
$ -17.73M$ -15.03M$ -13.93M$ -5.71M$ -9.73M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -16.55M$ -24.48M$ -16.85M$ -6.91M$ -7.03M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

COSCIENS Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis